Inventor · disambiguated record
Young Deug Kim
Also filed as: KIM I YOUNG DEUG · KIM YOUNG DEUG
20 granted patents·10 pending applications·33 citations·filing 1996–2020
91Inventor score
Top patents by PatentIndex Score
30 records- 0183US10655187B2Genetic marker for early breast cancer prognosis prediction and diagnosis, and use thereofGENCURIX INC·Filed 2018·Granted May 19, 2020·3 cites·3 claims
- 0283US8501689B2Growth factor-mimicking peptides and uses thereofCHUNG YONG-JI·Filed 2009·Granted Aug 6, 2013·4 cites·4 claims
- 0380US8106017B2Peptides for promoting hair growth and improving wrinkle and cosmetic compositions comprising the sameCHUNG YONG JI·Filed 2006·Granted Jan 31, 2012·6 cites·8 claims
- 0479US8969296B2TGFP-CAP peptide and its usesCHUNG YONG-JI·Filed 2007·Granted Mar 3, 2015·4 cites·6 claims
- 0576US8729028B2Noggin-derived peptide and use thereofCHUNG YOUNG JI·Filed 2009·Granted May 20, 2014·4 cites·6 claims
- 0676US8691195B2Peptide having activity of transforming growth factor and production method thereforCHUNG YOUNG JI·Filed 2009·Granted Apr 8, 2014·3 cites·7 claims
- 0776US7939495B2Method for improving skin conditionsCAREGEN CO LTD·Filed 2006·Granted May 10, 2011·3 cites·7 claims
- 0859US2021368880A1Detachable capture device for biomaterialsKOREA GENE INFORMATION INST CO LTD·Filed 2020·Application pending·0 cites
- 0958US10576158B2Immune conjugate having dendron conjugated to antibody and use thereofABION INC·Filed 2017·Granted Mar 3, 2020·0 cites·11 claims
- 1055US10428386B2Gene for predicting the prognosis for early-stage breast cancer, and a method for predicting the prognosis for early-stage breast cancer by using the sameGENCURIX INC·Filed 2016·Granted Oct 1, 2019·0 cites·3 claims
- 1155US2020009185A1METHOD FOR MAINTAINING INCREASED INTRACELLULAR p53 LEVEL, INDUCED BY PLATINUM-BASED ANTICANCER DRUG, AND APPLICATION THEREOFENHANCEDBIO INC·Filed 2019·Application pending·0 cites
- 1254US12173074B2Anti-c-Met agonist antibody and use thereofSEOUL NAT UNIV R&DB FOUNDATION·Filed 2019·Granted Dec 24, 2024·0 cites·11 claims
- 1354US2009169491A1Peptides Having Activities of Insulin Like Growth Factor-1 and their UsesCAREGEN CO LTD·Filed 2007·Application pending·0 cites
- 1453US9719093B2Composition for treating cancer associated with HPV infectionABION INC·Filed 2013·Granted Aug 1, 2017·0 cites·3 claims
- 1553US2018153932A1METHOD FOR MAINTAINING INCREASED INTRACELLULAR p53 LEVEL, INDUCED BY PLATINUM-BASED ANTICANCER DRUG, AND APPLICATION THEREOFABION INC·Filed 2017·Application pending·0 cites
- 1651US12098198B2Antibody binding specifically to ECL-2 of claudin 3, fragment thereof, and use thereofABION INC·Filed 2019·Granted Sep 24, 2024·0 cites·17 claims
- 1751US2022220208A1Anti-c-met agonist antibody and use thereofSEOUL NAT UNIV R&DB FOUNDATION·Filed 2019·Application pending·0 cites
- 1850US10806799B2Human interferon-beta variant conjugated immunocytokine and method for preparing sameGENOPHARM INC·Filed 2017·Granted Oct 20, 2020·0 cites·10 claims
- 1950US2013344482A1Gene for predicting the prognosis for early-stage breast cancer, and a method for predicting the prognosis for early-stage breast cancer by using the sameGENCURIX INC·Filed 2013·Application pending·0 cites
- 2049US10221418B2Composition for treating cancer associated with HPV infectionENHANCEDBIO INC·Filed 2017·Granted Mar 5, 2019·0 cites·4 claims
- 2149US8263095B2Methods of use for peptides having activities of insulin like growth factor-1CHUNG YONG JI·Filed 2010·Granted Sep 11, 2012·0 cites·5 claims
- 2248US8188049B2Peptides having activities of epidermal growth factor and its usesCHUNG YONG-JI·Filed 2007·Granted May 29, 2012·0 cites·10 claims
- 2348US6265590B1Nα-2-(4-nitrophenylsulfonyl)ethoxycarbonyl-amino acidsHYUNDAI PHARM IND CO LTD·Filed 1996·Granted Jul 24, 2001·6 cites·6 claims
- 2448US2021009720A1Human interferon-beta variant conjugated immunocytokine and method for preparing sameGENOPHARM INC·Filed 2020·Application pending·0 cites
- 2546US2017198291A1Composition for treating cancer associated with hpv infectionABION INC·Filed 2017·Application pending·0 cites
- 2640US9751941B2Antigen derived from extracellular domain of multi-transmembrane protein and uses thereofREFERENCE BIOLABS INC·Filed 2013·Granted Sep 5, 2017·0 cites·6 claims
- 2739US11759500B2PEGylated interferon-beta variantABION INC·Filed 2015·Granted Sep 19, 2023·0 cites·12 claims
- 2834US2016102359A1Genetic marker for early breast cancer prognosis prediction and diagnosis, and use thereofGENCURIX INC·Filed 2015·Application pending·0 cites
- 2932US2018135055A1Composition for cancer cell sensitization containing as active ingredient substance inhibiting expression of oncogene of hpv virusABION INC·Filed 2018·Application pending·0 cites
- 3026US12359172B2Method for preparing 3D cartilage organoid blockXCELL THERAPEUTICS INC·Filed 2016·Granted Jul 15, 2025·0 cites·3 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →